Company profile: Xcell Biosciences
1.1 - Company Overview
Company description
- Provider of a next-generation development and manufacturing platform for enhanced cell therapy performance, offering AVATAR Foundry, an automated closed system for autologous cell therapy production (in beta); AVATAR System, an incubator that fine-tunes oxygen and pressure to mimic in vivo; AVATAR AI, software using machine learning for drug behavior prediction and potency assay development; and AVATAR AD, a four-instrument system for assay development.
Products and services
- AVATAR AI: ML-driven software that predicts drug behavior and develops potency assays for cell therapy products using machine learning algorithms
- AVATAR Foundry: Industrial-grade automated, closed system for producing autologous cell therapies, currently in beta testing
- AVATAR System: Precision-controlled incubator engineered for cultivating primary human cells, finely tuning oxygen and pressure levels to mimic in vivo conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Xcell Biosciences
Nanobiotix
HQ: France
Website
- Description: Provider of nanomedicine therapeutics for the local treatment of cancer. Develops NanoXray, a technology using inert particles to destroy cancer cells. Products include magnetic particles and laser-activated nanoparticles for treatment and diagnostic. Offers NBTXR3, a radioenhancer that increases radiotherapy dose in tumor cells without affecting surrounding healthy tissues across solid tumors, and leads NANORAY-312, a phase 3 trial in HNSCC.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanobiotix company profile →
OncoMed
HQ: United States
Website
- Description: Provider of biotechnology therapeutics developing monoclonal antibodies that target pathways critical to tumor-initiating (cancer stem) cells to improve cancer treatment. Pipeline includes etigilimab with nivolumab for advanced solid tumors, navicixizumab for platinum-resistant ovarian cancer (with OncXerna), setrusumab for OI, alvelestat for AATD-LD, acumapimod for AECOPD, and leflutrozole (with ReproNovo).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoMed company profile →
Medfusion Services
HQ: United States
Website
- Description: Provider of integrated clinical laboratory and clinical trial services, offering diagnostic testing (solid tumor, hematopathology, women's health, urology, general health), molecular diagnostics and test development, pathology services, and clinical trial support including specimen collection, processing, testing, and guidance for specimen packaging and shipping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfusion Services company profile →
Miroculus
HQ: United States
Website
- Description: Provider of hands-off sample-to-answer solutions for molecular testing, delivering assay flexibility and automation via an affordable digital microfluidics platform that enables seamless workflow integration from novel molecular protocols to data analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miroculus company profile →
Clinical Laserthermia Systems
HQ: Sweden
Website
- Description: Provider of the TRANBERG® Thermal Therapy System and disposable materials for image-guided, minimally invasive laser ablation and heat-induced immunotherapy (imILT®), offering focal therapy for localized prostate cancer, careful therapy of brain lesions/epileptogenic foci, immune-stimulating laser ablation, and the Thermoguide Workstation for real-time treatment monitoring and control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Laserthermia Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Xcell Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Xcell Biosciences
2.2 - Growth funds investing in similar companies to Xcell Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Xcell Biosciences
4.2 - Public trading comparable groups for Xcell Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →